Heping Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 5
- Ubiquitin and proteasome pathways 2
- Oncology 9
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Qiangsheng Dai (9 shared papers)Guosheng Tan (9 shared papers)Jianting Long (8 shared papers)Binhui Xie (13 shared papers)Bing Zhang (10 shared papers)Jianyong Yang (8 shared papers)Shiqiu Xiong (9 shared papers)Xiaonong Wang (4 shared papers)
- Journals
- Journal of Translational Medicine (3 papers)PLoS ONE (2 papers)Anti-Cancer Drugs (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Heping Li
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 405
- Molecular Biology 649
- Hepatology 62
- Oncology 198
- Biomaterials 82
Countries citing papers authored by Heping Li
This map shows the geographic impact of Heping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heping Li more than expected).
Fields of papers citing papers by Heping Li
This network shows the impact of papers produced by Heping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heping Li. The network helps show where Heping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Heping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 103 | |
| 2 | 2013 | 83 | |
| 3 | 2014 | 72 | |
| 4 | 2015 | 70 | |
| 5 | 2015 | 64 | |
| 6 | 2016 | 56 | |
| 7 | 2019 | 54 | |
| 8 | 2018 | 53 | |
| 9 | 2014 | 53 | |
| 10 | 2016 | 49 | |
| 11 | 2017 | 48 | |
| 12 | 2018 | 47 | |
| 13 | 2014 | 38 | |
| 14 | 2019 | 34 | |
| 15 | 2017 | 30 | |
| 16 | 2020 | 29 | |
| 17 | 2015 | 29 | |
| 18 | 2014 | 27 | |
| 19 | 2019 | 23 | |
| 20 | 2021 | 20 |
About Heping Li
Heping Li is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Ubiquitin and proteasome pathways (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Spectroscopy and Chemometric Analyses (2 papers). The work is most often cited by research in Cancer Research (405 citations), Molecular Biology (649 citations), Hepatology (62 citations), Oncology (198 citations) and Biomaterials (82 citations). Heping Li has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Qiangsheng Dai, Guosheng Tan, Jianting Long, Binhui Xie, Bing Zhang, Jianyong Yang, Shiqiu Xiong, Xiaonong Wang, Ruifang Zeng and Bing Zhang. Their work appears in journals such as Journal of Translational Medicine, PLoS ONE, Anti-Cancer Drugs, Journal of Experimental & Clinical Cancer Research and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.